Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/20/2024 | $7.50 → $7.00 | Equal Weight → Underweight | Wells Fargo |
| 7/19/2024 | Neutral | BTIG Research | |
| 3/4/2024 | $11.00 → $7.00 | Buy → Underperform | BofA Securities |
| 12/6/2023 | $10.50 | Neutral | UBS |
| 12/5/2023 | Mkt Outperform → Mkt Perform | JMP Securities | |
| 9/13/2023 | $10.00 | Equal Weight | Wells Fargo |
| 8/18/2023 | Outperform → Mkt Perform | Raymond James | |
| 4/25/2023 | Buy → Neutral | BTIG Research |
First quarter GAAP net income of $9.3 million or $0.17 per diluted common share and Distributable Earnings(1) of $7.2 million or $0.13 per diluted common share - Subsequent to the three months ended March 31, 2025 - Declared second quarter 2025 dividend of $0.15 per common share Ares Commercial Real Estate Corporation (the "Company") (NYSE:ACRE), a specialty finance company primarily engaged in directly originating and investing in commercial real estate assets, reported generally accepted accounting principles ("GAAP") net income of $9.3 million or $0.17 per diluted common share and Distributable Earnings(1) of $7.2 million or $0.13 per diluted common share for the first quarter of 2025
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that it will report earnings for the first quarter ended March 31, 2025 on Wednesday, May 7, 2025 prior to the opening of the New York Stock Exchange. Ares Commercial Real Estate Corporation will hold its webcast/conference call on the same day at 12:00 p.m. Eastern Time to discuss its first quarter ended March 31, 2025 financial results. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Home page of the Investor Resources section of our website at http://www.arescre.com. Please visit the website to test your connection before the webc
Fourth quarter GAAP net income (loss) of $(10.7) million or $(0.20) per diluted common share and Distributable Earnings (Loss)(1) of $(8.3) million or $(0.15) per diluted common share Full year GAAP net income (loss) of $(35.0) million or $(0.64) per diluted common share and Distributable Earnings (Loss)(1) of $(44.6) million or $(0.82) per diluted common share - Subsequent to the year ended December 31, 2024 - Declared first quarter 2025 dividend of $0.15 per common share Collected $166 million in repayments resulting in available capital of over $200 million(2) Ares Commercial Real Estate Corporation (the "Company") (NYSE:ACRE), a specialty finance company primarily engaged in d
8-K - Ares Commercial Real Estate Corp (0001529377) (Filer)
10-Q - Ares Commercial Real Estate Corp (0001529377) (Filer)
8-K - Ares Commercial Real Estate Corp (0001529377) (Filer)
First quarter GAAP net income of $9.3 million or $0.17 per diluted common share and Distributable Earnings(1) of $7.2 million or $0.13 per diluted common share - Subsequent to the three months ended March 31, 2025 - Declared second quarter 2025 dividend of $0.15 per common share Ares Commercial Real Estate Corporation (the "Company") (NYSE:ACRE), a specialty finance company primarily engaged in directly originating and investing in commercial real estate assets, reported generally accepted accounting principles ("GAAP") net income of $9.3 million or $0.17 per diluted common share and Distributable Earnings(1) of $7.2 million or $0.13 per diluted common share for the first quarter of 2025
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that it will report earnings for the first quarter ended March 31, 2025 on Wednesday, May 7, 2025 prior to the opening of the New York Stock Exchange. Ares Commercial Real Estate Corporation will hold its webcast/conference call on the same day at 12:00 p.m. Eastern Time to discuss its first quarter ended March 31, 2025 financial results. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Home page of the Investor Resources section of our website at http://www.arescre.com. Please visit the website to test your connection before the webc
Fourth quarter GAAP net income (loss) of $(10.7) million or $(0.20) per diluted common share and Distributable Earnings (Loss)(1) of $(8.3) million or $(0.15) per diluted common share Full year GAAP net income (loss) of $(35.0) million or $(0.64) per diluted common share and Distributable Earnings (Loss)(1) of $(44.6) million or $(0.82) per diluted common share - Subsequent to the year ended December 31, 2024 - Declared first quarter 2025 dividend of $0.15 per common share Collected $166 million in repayments resulting in available capital of over $200 million(2) Ares Commercial Real Estate Corporation (the "Company") (NYSE:ACRE), a specialty finance company primarily engaged in d
Ares Commercial Real Estate Corporation announced today that it has appointed Rebecca Parekh to its Board of Directors, effective immediately. Ms. Parekh's appointment expands the Board from seven to eight members, including six independent board members. Ms. Parekh is the Co-Founder and Chief Executive Officer of The Well, a series of wellness facilities. Previously, she served as the Chief Operating Officer for Deepak Chopra Radical Well-Being, LLC. Prior to that, Ms. Parekh spent ten years at Deutsche Bank Securities, Inc., focused primarily on structured credit where she held various positions, including Head of the U.S. Private Institutional Client Group and Head of Cross Product Sale
SC 13G/A - Ares Commercial Real Estate Corp (0001529377) (Subject)
SC 13G/A - Ares Commercial Real Estate Corp (0001529377) (Subject)
SC 13G - Ares Commercial Real Estate Corp (0001529377) (Subject)
Wells Fargo downgraded Ares Commercial Real Estate from Equal Weight to Underweight and set a new price target of $7.00 from $7.50 previously
BTIG Research resumed coverage of Ares Commercial Real Estate with a rating of Neutral
BofA Securities downgraded Ares Commercial Real Estate from Buy to Underperform and set a new price target of $7.00 from $11.00 previously
4 - Ares Commercial Real Estate Corp (0001529377) (Issuer)
4 - Ares Commercial Real Estate Corp (0001529377) (Issuer)
4 - Ares Commercial Real Estate Corp (0001529377) (Issuer)
4 - Ares Commercial Real Estate Corp (0001529377) (Issuer)